Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00431301 · ClinicalTrials.gov registry record
Risk Factors for Progressive Supranuclear Palsy (PSP)
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 942
- Enrollment target
NCT00431301 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 942 participants.
The verdict
NCT00431301 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 942 participants
- Enrollment target
Study Summary
Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian movement disorder. This study will determine the role of specific genetic, occupational and environmental components in the development of PSP by evaluating patients with this disorder and age and gender matched controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 942 participants |
| Start Date | 2006-08 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00431301
The ClinicalTrials.gov registry entry for NCT00431301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 942 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00431301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00431301 about?
NCT00431301 is a clinical study titled "Risk Factors for Progressive Supranuclear Palsy (PSP)". Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian movement disorder. This study will determine the role of specific genetic, occupational and environmental components in the development of PSP by evaluating patients with this disorder and age and gender matched controls.
What is the current status of trial NCT00431301?
This trial is currently completed. The enrollment target is 942 participants. The study started on 2006-08. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00431301?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.